Generics BulletinHBW InsightIn VivoMedtech InsightPink SheetScrip

Generics Bulletin

Medtech Insight

IPO Update: Gottlieb’s Resignation Pulls Down Five Of Eight Newly Public Biopharmas

IPO Initial Private Offering Stock Market Ticker Building 3d Illustration

Related Content

Series A Deal Volume And Money Up In H1

Sep 10 2015

J.P. Morgan 2019: Industry Throws A Bonanza, With An Elephant In The Room

Jan 10 2019

Biogen By Buying Nightstar Targets Ophthalmology As Emerging Growth Area

Mar 04 2019

Gottlieb's Short Tenure Will Be Felt Long After He Leaves US FDA

Mar 06 2019

Finance Watch: Gossamer, Alector And Harpoon Launch First Biopharma IPOs Of 2019

Feb 09 2019

Finance Watch: Anchiano, TCR2, Hoth And Stealth Make Seven US Biopharma IPOs For 2019

Feb 25 2019

Intercept Retakes The Lead In NASH

Feb 19 2019

Roche $4.8bn Buy Sparks Hemophilia Gene Therapy Race

Feb 25 2019

Bristol Values Celgene's Hematology, Immunology Portfolio At $74bn, But Does It Price In Risk?

Jan 04 2019

IPO Update: Returns Run Red For Most Biopharma Firms That Went Public In The US Last Year

Jan 04 2019

UK's Nightstar NASDAQ Listing Backs British Biotech Build-Up Strategy

Sep 28 2017

Cirius Eyes Phase III Plans In NASH With Interim Data Showing Liver, Metabolic Benefits

Oct 26 2018

Deal Watch: Cigna Acquisition Of Express Scripts OKed By US Justice Dept.

Sep 17 2018

Top Financings: 2018 Was A Remarkable Year For Biopharma Fundraising

Jan 09 2019

Finance Watch: Investors Can't Get Enough Of NASH, Including Start-Ups With Novel Drugs

Nov 02 2018

Finance Watch: Alphamab's $100m Series A Continues Theme Of Big Investments In China Biopharma

Nov 23 2018

Finance Watch: Biopharma IPOs Defy Broader Stock Performance Trends

Mar 09 2018

Venture Funding Deals: I-Mab Is The Mega-Round Leader With $220m Series C

Jul 05 2018

Related Companies

Kaleido Biosciences, Inc.

Gossamer Bio, Inc.

Alector, Inc.

Harpoon Therapeutics

Anchiano Therapeutics Ltd.

TCR² Therapeutics Inc.

Stealth BioTherapeutics Inc.

Hoth Therapeutics, Inc.

Bristol Myers Squibb Company

Bristol Myers Squibb Company

Spark Therapeutics, Inc.

Roche Holding AG

AVROBIO, Inc.

Homology Medicines, Inc.

Nightstar Therapeutics plc

Astellas Gene Therapies

Regenxbio Inc.

uniQure N.V.

Biogen, Inc.

Genfit SA

Intercept Pharmaceuticals, Inc.

Precision BioSciences, Inc.

Gilead Sciences, Inc.

Cirius Therapeutics, Inc.

PolyPid Ltd.

Additional Topics

Financing Business Strategies Commercial BioPharmaceutical

More from Financing

More from Business

About Us

Meet the TeamOpens in new window
RSS FeedOpens in new window

Contact Us

Customer Service
SubscribeOpens in new window
AdvertisingOpens in new window
Feedback

Terms and ConditionsOpens in new window

Privacy PolicyOpens in new window